Profile data is unavailable for this security.
About the company
HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.
- Revenue in JPY (TTM)121.00m
- Net income in JPY-3.82bn
- Incorporated2011
- Employees64.00
- LocationHealios KK11F, Seiroka Tower, 8-1, Akashi-choCHIYODA-KU 100-0006JapanJPN
- Phone+81 345908006
- Fax+81 335448760
- Websitehttps://www.healios.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kohjin Bio Co Ltd | -100.00bn | -100.00bn | 9.46bn | 157.00 | -- | 2.97 | -- | -- | -- | -- | -- | 634.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.15 | -- | 0.4102 | -- | 20.16 | -- | 41.20 | -- | -- | -- |
| 3-D Matrix Ltd | 3.74bn | -1.06bn | 9.52bn | 108.00 | -- | 15.49 | -- | 2.55 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
| TMS Co Ltd | 0.00 | -960.04m | 9.91bn | 14.00 | -- | 2.87 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | -- | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -11.51 | -- | -- | -- |
| Linical Co Ltd | 12.52bn | 680.40m | 9.97bn | 759.00 | 13.38 | 1.16 | 8.38 | 0.7964 | 30.12 | 30.12 | 554.28 | 346.38 | 0.7251 | -- | 3.99 | 16,494,230.00 | 3.94 | 4.71 | 6.55 | 7.23 | 33.10 | 31.60 | 5.43 | 5.98 | -- | 17,809.03 | 0.2793 | 45.36 | 8.32 | 6.55 | 27.06 | -4.97 | -33.01 | 4.94 |
| AnGes Inc | 152.99m | -7.44bn | 10.67bn | 145.00 | -- | 0.3726 | -- | 69.72 | -39.40 | -39.40 | 0.8083 | 131.52 | 0.0045 | 0.1037 | 8.40 | 1,055,069.00 | -21.97 | -28.50 | -25.69 | -33.14 | 12.71 | 39.42 | -4,861.66 | -6,726.82 | 1.75 | -- | 0.0137 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| KOEI CHEMICAL COMPANY, LIMITED | 18.49bn | 62.58m | 11.07bn | 387.00 | 176.56 | 0.509 | 3.76 | 0.5987 | 12.79 | 12.79 | 3,779.78 | 4,437.99 | 0.4599 | 1.30 | 4.51 | 47,770,930.00 | 0.1557 | 3.76 | 0.206 | 4.68 | 24.91 | 24.12 | 0.3385 | 6.66 | 0.5356 | 1.77 | 0.3089 | 35.80 | 7.55 | 0.4997 | -26.56 | -33.82 | 15.68 | 20.11 |
| Veritas In Silico Inc | 360.36m | 33.05m | 11.23bn | 15.00 | 330.05 | 6.92 | 187.18 | 31.16 | 5.24 | 5.24 | 57.19 | 250.05 | -- | -- | -- | 24,023,730.00 | -- | -- | -- | -- | -- | -- | 9.17 | -- | 20.19 | -- | 0.00 | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Medinet Co Ltd | 724.63m | -1.41bn | 11.53bn | 98.00 | -- | 1.97 | -- | 15.91 | -6.31 | -6.31 | 3.23 | 22.88 | 0.1224 | 11.93 | 3.61 | 7,394,143.00 | -23.74 | -21.05 | -24.75 | -22.47 | 17.72 | 28.75 | -193.90 | -135.40 | 19.58 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
| ReproCell Inc | 2.51bn | -217.49m | 12.19bn | 92.00 | -- | 1.51 | -- | 4.86 | -2.56 | -2.56 | 29.48 | 90.90 | 0.3008 | 4.86 | 7.44 | 27,247,390.00 | -2.61 | -9.37 | -2.80 | -10.11 | 43.55 | 38.78 | -8.68 | -38.12 | 11.94 | -- | 0.00 | -- | 32.16 | 26.10 | 46.91 | -- | 28.24 | -- |
| Nano Mrna Co Ltd | 164.39m | -1.05bn | 12.74bn | 17.00 | -- | 3.66 | -- | 77.51 | -14.94 | -14.94 | 2.34 | 49.40 | 0.0295 | 18.96 | 2.60 | 9,669,765.00 | -18.85 | -25.13 | -23.29 | -26.04 | 80.67 | 84.69 | -638.22 | -538.31 | 8.95 | -- | 0.2418 | -- | -23.42 | -4.84 | 30.33 | -- | -- | -- |
| RaQualia Pharma Inc | 1.90bn | -323.66m | 12.87bn | 67.00 | -- | 2.10 | -- | 6.77 | -14.99 | -14.99 | 87.98 | 283.05 | 0.2896 | 3.13 | 3.15 | 28,376,150.00 | -4.93 | 2.13 | -5.29 | 2.26 | 87.11 | 88.49 | -17.02 | 5.32 | 12.35 | -- | 0.0567 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| Healios KK | 121.00m | -3.82bn | 13.34bn | 64.00 | -- | 2.86 | -- | 110.24 | -55.07 | -55.07 | 1.78 | 51.71 | 0.008 | -- | 0.3929 | 1,890,625.00 | -25.27 | -23.55 | -35.99 | -28.52 | 83.47 | -- | -3,152.89 | -6,580.16 | -- | -13.68 | 0.6756 | -- | 34.44 | -- | 26.04 | -- | -22.00 | -- |
| Ohki Healthcare Holdings Co Ltd | 327.51bn | 2.35bn | 14.24bn | 576.00 | 5.94 | 0.5287 | 5.37 | 0.0435 | 170.32 | 170.32 | 23,747.19 | 1,914.31 | 2.37 | 11.64 | 4.27 | 568,593,700.00 | 1.65 | 1.95 | 7.98 | 9.11 | 5.20 | 7.12 | 0.6962 | 0.7539 | 0.8536 | -- | 0.19 | 13.28 | 9.45 | 4.91 | 124.49 | -1.16 | -1.27 | 9.46 |
| Oncolys Biopharma Inc | 63.04m | -1.94bn | 14.57bn | 34.00 | -- | 9.25 | -- | 231.10 | -108.23 | -108.23 | 3.54 | 75.10 | 0.0269 | 2.19 | 0.3001 | 1,854,059.00 | -82.64 | -45.75 | -97.13 | -51.86 | 48.55 | 60.46 | -3,075.14 | -233.66 | 5.15 | -- | 0.1761 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Microwave Chemical Co Ltd | 1.89bn | 98.88m | 15.61bn | 59.00 | 224.45 | 9.14 | 88.64 | 8.25 | 4.45 | 4.45 | 116.78 | 109.32 | 0.6526 | 9.37 | 6.53 | 32,055,120.00 | 3.41 | -- | 4.65 | -- | 54.51 | -- | 5.23 | -- | 2.65 | 11.24 | 0.2309 | -- | 41.24 | -- | 168.39 | -- | -- | -- |
Data as of May 01 2024. Currency figures normalised to Healios KK's reporting currency: Japanese Yen JPY
19.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Athos Capital Ltd.as of 09 Feb 2024 | 13.50m | 14.98% |
| Oasis Management (Hong Kong) LLCas of 09 Feb 2024 | 1.04m | 1.16% |
| Mirabella Financial Services LLPas of 09 Feb 2024 | 1.04m | 1.16% |
| Heights Capital Management, Inc.as of 02 Feb 2024 | 640.10k | 0.71% |
| Panview Capital Ltd.as of 09 Aug 2023 | 543.40k | 0.60% |
| Maven Investment Partners Ltd.as of 12 Oct 2023 | 413.70k | 0.46% |
| Meiji Yasuda Asset Management Co. Ltd.as of 22 May 2023 | 372.20k | 0.41% |
| Rheos Capital Works, Inc. (Investment Management)as of 30 Sep 2022 | 162.60k | 0.18% |
| Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 129.00k | 0.14% |
| Asset Management One Co., Ltd.as of 15 May 2023 | 9.00k | 0.01% |
More ▼
Data from 31 Dec 2023 - 19 Apr 2024Source: FactSet Research Systems Inc.
